Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

CD38 Expression As an Additional Prognostic Marker in Mantle Cell Lymphoma

Matteo D'Addona, Luca Pezzullo, Valentina Giudice, Danilo De Novellis, Idalucia Ferrara, Raffaele Fontana, Roberto Guariglia, Serena Luponio, Laura Mettivier, Maria Carmen Martorelli, Andrea Gigantiello, Denise Morini, Michela Rizzo, Maria Teresa Buonanno, Giuseppe Ciancia, Marisa Gorrese, Bianca Serio, Carmine Selleri

Blood (2024) 144 (Supplement 1): 6250.

https://doi.org/10.1182/blood-2024-198812

Published: 2024

Journal Articles

Real-World Use and Outcome of Ropeginterferon ALFA-2B in Polycythemia VERA Patients: A Multicenteric Study

Novella Pugliese, Maria Di Perna, Ugo De martino, Valeria Amico, Mario Annunziata, Maria Carmen Martorelli, Davide Pio Abagnale, Roberta Russo, Maria Ferrentino, Alessia Scarpa, Francesco Muriano, Vincenzo Martinelli, Fabrizio Pane

Blood (2024) 144 (Supplement 1): 6651.

https://doi.org/10.1182/blood-2024-210785

Published: 2024

Journal Articles

Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors

Valentina Giudice, Marisa Gorrese, Idalucia Ferrara, Rita Pepe, Angela Bertolini, Rosa Vitolo, Rossella Marcucci, Paola Manzo, Matteo D'Addona, Maria Carmen Martorelli, Maria Teresa Buonanno, Maddalena Langella, Bianca Serio, Carmine Selleri

Blood (2021) 138 (Supplement 1): 4448.

https://doi.org/10.1182/blood-2021-150727

Published: 2021

Journal Articles

No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura

Giovanni D'Arena, Roberto Guariglia, Giovanna Mansueto, Maria Carmen Martorelli, Giuseppe Pietrantuono, Oreste Villani, Rosa Lerose, Pellegrino Musto

Blood (2013) 121 (7): 1240–1242.

https://doi.org/10.1182/blood-2012-11-465575

Published: 2013

Journal Articles

How Epidemiology of Polycythemia Vera Has Changed in the Last 10 Years: Results From the Whole Prospective Cohort of Patients in Cyto-PV Trial As Compared with Eclap Prospective Cohort

Blood (2012) 120 (21): 1748.

https://doi.org/10.1182/blood.V120.21.1748.1748

Published: 2012

Journal Articles

A Large-Scale Trial Testing the Intensity of Cytoreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial)

Blood (2012) 120 (21): 4.

https://doi.org/10.1182/blood.V120.21.4.4

Published: 2012

Journal Articles

Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients.

Blood (2012) 120 (21): 2971.

https://doi.org/10.1182/blood.V120.21.2971.2971

Published: 2012

Journal Articles

Lenalidomide and Low Dose Dexamethasone As First Line Therapy for Newly Diagnosed Patients with Primary Plasma Cell Leukemia

Blood (2012) 120 (21): 729.

https://doi.org/10.1182/blood.V120.21.729.729

Published: 2012

Journal Articles

Final Results of a Phase II Study Evaluating Lenalidomide in Combination with Low Dose Dexamethasone As First Line Therapy for Primary Plasma Cell Leukemia

Blood (2011) 118 (21): 2925.

https://doi.org/10.1182/blood.V118.21.2925.2925

Published: 2011

Journal Articles

A Pilot Study of Lenalidomide and Dexamethasone as First Line Therapy in Patients with Primary Plasma Cell Leukemia.

Pellegrino Musto, Maria Teresa Petrucci, Fortunato Morabito, Francesco Nobile, Fiorella D'Auria, Rosa Lerose, Anna Sparano, Antonia Zonno, Vincenzo Callea, Anna Levi, Carla Mazzone, Giuseppe Pietrantuono, Maria Carmen Martorelli, Antonino Neri, Paola Omedè, Sara Bringhen, Michele Cavo, Mario Boccadoro, Antonio Palumbo

Blood (2009) 114 (22): 4951.

https://doi.org/10.1182/blood.V114.22.4951.4951

Published: 2009

Journal Articles

Efficacy of Lenalidomide in Primary Plasma Cell Leukemia.

Giuseppe Pietrantuono, Roberto Guariglia, Maria Carmen Martorelli, Oreste Villani, Fiorella D’Auria, Pellegrino Musto

Blood (2007) 110 (11): 4835.

https://doi.org/10.1182/blood.V110.11.4835.4835

Published: 2007

Journal Articles

Final Analysis of a Multicenter, Randomised Study Comparing Zoledronate vs Observation in Patients with Asymptomatic Myeloma.

Pellegrino Musto, Maria Teresa Petrucci, Sara Bringhen, Tommasina Guglielmelli, Tommaso Caravita, Enrico Balleari, Alessandro Andriani, Giovanni D’Arena, Velia Bongarzoni, Roberto Guariglia, Giuseppe Pietrantuono, Oreste Villani, Maria Carmen Martorelli, Fiorella D’Auria, Pasquale Niscola, Antonietta Falcone, Grazia Sanpaolo, Antonio Palumbo

Blood (2007) 110 (11): 534.

https://doi.org/10.1182/blood.V110.11.534.534

Published: 2007

Journal Articles

Combination of Rituximab, Bortezomib and Hyper-Fractionated Cyclophosphamide (RBC) in “True” Elderly Patients with Advanced Mantle Cell Lympoma.

Roberto Guariglia, Giuseppe Pietrantuono, Oreste Villani, Maria Carmen Martorelli, Fiorella D’Auria, Angela Zupa, Gabriella Bianchino, Vitina Grieco, Luigina Digiovannantonio, Alessandra Benvenuto, Elisa Feudale, Antonello Pinto, Felicetto Ferrara, Pellegrino Musto

Blood (2007) 110 (11): 4448.

https://doi.org/10.1182/blood.V110.11.4448.4448

Published: 2007

Journal Articles

Darbepoetin 500 mcg Q3W, Alone or in Combination with Peg-Filgrastim, in Low/Int1 IPSS Risk Myelodysplastic Syndromes Unresponsive to Recombinant Erythropoietin.

Oreste Villani, Roberto Guariglia, Giuseppe Pietrantuono, Maria Carmen Martorelli, Fiorella D’Auria, Carla Papa, Rosa Lerose, Laura Campioni, Francesco Lanza, Pellegrino Musto

Blood (2007) 110 (11): 4606.

https://doi.org/10.1182/blood.V110.11.4606.4606

Published: 2007

NARROW

CD38 Expression As an Additional Prognostic Marker in Mantle Cell Lymphoma

Real-World Use and Outcome of Ropeginterferon ALFA-2B in Polycythemia VERA Patients: A Multicenteric Study

Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors

No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura

How Epidemiology of Polycythemia Vera Has Changed in the Last 10 Years: Results From the Whole Prospective Cohort of Patients in Cyto-PV Trial As Compared with Eclap Prospective Cohort

A Large-Scale Trial Testing the Intensity of Cytoreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial)

Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients.

Lenalidomide and Low Dose Dexamethasone As First Line Therapy for Newly Diagnosed Patients with Primary Plasma Cell Leukemia

Final Results of a Phase II Study Evaluating Lenalidomide in Combination with Low Dose Dexamethasone As First Line Therapy for Primary Plasma Cell Leukemia

A Pilot Study of Lenalidomide and Dexamethasone as First Line Therapy in Patients with Primary Plasma Cell Leukemia.

Bortezomib as Front-Line Therapy in Primary Plasma Cell Leukemia

Efficacy of Lenalidomide in Primary Plasma Cell Leukemia.

Final Analysis of a Multicenter, Randomised Study Comparing Zoledronate vs Observation in Patients with Asymptomatic Myeloma.

Combination of Rituximab, Bortezomib and Hyper-Fractionated Cyclophosphamide (RBC) in “True” Elderly Patients with Advanced Mantle Cell Lympoma.

Darbepoetin 500 mcg Q3W, Alone or in Combination with Peg-Filgrastim, in Low/Int1 IPSS Risk Myelodysplastic Syndromes Unresponsive to Recombinant Erythropoietin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only